Request for Proposals - Independent Medical Education

The grant review process evaluates all grant applications based upon perceived educational need, design, scientific rigor of the proposal and compliance with both industry and argenx independent medical education guidelines.

The approval of a proposal will depend on available funding and alignment with the educational areas of interest as outlined in the argenx IME RFP. All decisions regarding grant proposals are made through a formal, grant review and decision-making process by the argenx independent medical education review committee.

All submitted grant proposals are reviewed regardless of whether they were submitted in response to a current RFP, however, RFP responsive proposals will be prioritized. Should your organization be interested in submitting a proposal, please click on the hyperlink below for the Grants portal to start the process of submission. For any questions, please reach out to [email protected].

Current Open Request for Proposals:

Areas of Interest

  • Impact of gMG disease symptom on independent function, patient and caregiver burden, and quality of life
  • Limitations and considerations of existing therapies (e.g  time to effect, long-term toxicities, comorbidities which limit use, time to deliver medication)
  • Utilizing clinical presentation to inform treatment selection (e.g autoantibody status, generalized symptoms, age and comorbidities) 
  • Route of administration
    • Patient preference
    • Venous access 
    • Availability of infusion chairs  
  • Novel therapies and safety/tolerability, need for preventive vaccinations, efficacy, depth of response, duration of response 
  • Individualization of treatment 
    • Based on variability and fluctuation in symptoms 
    • Shared Patient - HCP decision making 
       

Program Format

  • Proposals for live IME symposia at Ig therapy focused congresses with multidisciplinary HCP audiences. 
      

Target Audience

  • Minimum IME requirement, 1 credit for all proposals. 
  • Physicians, pharmacists, nurses  


RFP Timeline

  • We will be accepting proposals until March 31, 2024 


Questions regarding this RFP must be submitted to [email protected]. To access the portal to submit a grant application please register and log into the argenx Grants portal. Thank you for your interest in argenx.

argenx supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, and education) to improve patient outcomes in areas of unmet medical need that are aligned with argenx medical and scientific strategies. Through this RFP, it is our intent to support CME/CE programs in the following areas of interest.
 

Areas of Interest

  • CIDP mechanism of disease and role of IgG autoantibodies  
  • Burden of disease and the challenges with historical treatments 
  • Diagnostic barriers in CIDP and strategies to promote timely and appropriate identification of the disease  
  • Limitations and considerations of available therapies (e.g time to effect, long-term toxicities, comorbidities which limit use, time to deliver medication) 
  • MOA, efficacy, safety, and place in therapy of emerging biologic treatments for CIDP  
  • The potential impact of emerging therapies on current international treatment guidance for CIDP 
     

Program Format

  • Program to start after July 31st, 2024 
  • Enduring content for at least 12-months after launch of program 
  • Preference for short video/interactive content or a variety of content formats to be included as recommended by IME provider 

  

Target Audience

  • Minimum CME/CE requirement, 1 credit for all proposals
  • Educational credits in North America
  • MDs, NPs, PAs, PharmD/RPh in neurology or neuroimmunology disease space. 
     

RFP Timeline

  • RFP Open: March 18th, 2024 
  • Application deadline: April 30th, 2024 
  • Grant award notification: June 15th 2024  


Questions regarding this RFP must be submitted to [email protected]. To access the portal to submit a grant application please register and log into the argenx Grants portal. Thank you for your interest in argenx.

 

argenx grants
Together We Discover